Dr. Quaovi Sodji completes his Bentson Fellowship

Dr. Quaovi Sodji receiving certificate from Dr. Zach Morris
Dr. Zach Morris (right), Program Director for the Bentson Translational Research Fellowship, presents Dr. Quaovi Sodji (left) with his fellowship completion certificate.

Dr. Quaovi Sodji recently completed his Bentson Translational Research Fellowship at the University of Wisconsin in the Department of Human Oncology. Dr. Sodji earned his MD at the Medical College of Georgia and his PhD in medicinal chemistry at the Georgia Institute of Technology. He then completed his radiation oncology residency and a one-year research fellowship at Stanford University. During his time as a Bentson Fellow, Dr. Sodji conducted multidisciplinary research aimed at enhancing the efficacy and safety of chimeric antigen receptor (CAR) T cell therapies for cancers by combining these with targeted radionuclide therapy. Among his many fellowship accomplishments, Dr. Sodji published peer-reviewed research, submitted multiple grant applications to the National Institutes of Health (NIH), and generated innovations that led to multiple patent filings by the Wisconsin Alumni Research Foundation. Dr. Sodji has now been recruited to join the faculty of the Department of Human Oncology as a tenure-track assistant professor and he will continue his translational research at the University of Wisconsin. The Bentson Translational Research Fellowship was established in 2015 following a generous donation from the Bentson Foundation. This program supports highly motivated and well-qualified cancer researchers who are focused on translating basic science discoveries into clinical advances. The fellowship provides comprehensive training and support for these individuals as they navigate the challenging transition from trainee to independent investigator.